Syndax Pharmaceuticals, Inc. (SNDX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 1.72B |
| Enterprise Value | 1.28B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 3.50 |
| Enterprise Value/Revenue | 7.85 |
| Enterprise Value/EBITDA | -91.79 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.01 |
| 52-Week Change 3 | -7.53% |
| S&P500 52-Week Change 3 | 28.04% |
| 52 Week High 3 | 25.34 |
| 52 Week Low 3 | 11.22 |
| 50-Day Moving Average 3 | 22.09 |
| 200-Day Moving Average 3 | 19.10 |
Share Statistics
| Avg Vol (3 month) 3 | 1.06M |
| Avg Vol (10 day) 3 | 941.79k |
| Shares Outstanding 5 | 84.99M |
| Implied Shares Outstanding 6 | 85.85M |
| Float 8 | 84.65M |
| % Held by Insiders 1 | 0.82% |
| % Held by Institutions 1 | 108.72% |
| Shares Short (Apr 30, 2024) 4 | 10.11M |
| Short Ratio (Apr 30, 2024) 4 | 11.26 |
| Short % of Float (Apr 30, 2024) 4 | 11.99% |
| Short % of Shares Outstanding (Apr 30, 2024) 4 | 11.90% |
| Shares Short (prior month Mar 28, 2024) 4 | 9.62M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | 0.00% |
Management Effectiveness
| Return on Assets (ttm) | -32.84% |
| Return on Equity (ttm) | -51.89% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -263.44M |
| Net Income Avi to Common (ttm) | -240.63M |
| Diluted EPS (ttm) | -3.24 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 443.16M |
| Total Cash Per Share (mrq) | 5.21 |
| Total Debt (mrq) | 1.39M |
| Total Debt/Equity (mrq) | 0.28% |
| Current Ratio (mrq) | 8.93 |
| Book Value Per Share (mrq) | 5.79 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -204.92M |
| Levered Free Cash Flow (ttm) | -112.12M |
© 2024 Yahoo. All rights reserved.